There is a lot of talk about research and medical advances
in the treatment of multiple sclerosis, but I would like to return to the fundamentals of MS
care and how these new treatment options fall into the framework of MS care.
There are three important arms of MS treatment:
1. Disease
Modifying Agents - Medications that are... Read more
The American Academy of Neurology had its annual meeting recently, where the newest in research is presented with the hope of better treatments. At this year's meeting, we heard a lot about updates of clinical trials we are all becoming familiar with:
Rituximab - the monoclonal antibody directed against B cells. You will remember that... Read more
Multiple Sclerosis care is so rewarding because it is so multi-faceted - from the different types of presentation, different patients, different personalities, and different medication options. Fifteen years ago there were no FDA approved medications for MS. That has changed rapidly and so the pipeline for new medications grows every year.... Read more